Current gene- and disease-informed specifications are under development for the MUTYH, POLE and POLD1 genes, and other adenomatous and hamartomatous polyposis genes will follow to optimize clinical management and opportunities for cancer prevention. The gene discussed is POLD1; the disease is cancer.